Yes, ALVs can be detected using various techniques. Immunohistochemistry and flow cytometry can be used to assess the expression of specific antigens on cancer cells. Additionally, genomic sequencing and epigenetic profiling can identify genetic or epigenetic changes associated with antigen loss. Monitoring for ALVs is crucial for adapting treatment strategies and improving patient outcomes.
